ibuprofen, (r)-isomer has been researched along with dexibuprofen in 6 studies
| Studies (ibuprofen, (r)-isomer) | Trials (ibuprofen, (r)-isomer) | Recent Studies (post-2010) (ibuprofen, (r)-isomer) | Studies (dexibuprofen) | Trials (dexibuprofen) | Recent Studies (post-2010) (dexibuprofen) |
|---|---|---|---|---|---|
| 10 | 0 | 4 | 81 | 8 | 53 |
| Protein | Taxonomy | ibuprofen, (r)-isomer (IC50) | dexibuprofen (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 3.535 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.9345 | |
| C-X-C chemokine receptor type 1 | Homo sapiens (human) | 0.1 | |
| C-X-C chemokine receptor type 2 | Homo sapiens (human) | 0.1 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 1.595 | |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 1.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Allegretti, M; Berdini, V; Bertini, R; Bizzarri, C; Cesta, MC; Colotta, F; Di Bello, N; Di Bitondo, R; Di Cioccio, V; Fantucci, P; Florio, S; Galliera, E; Locati, M; Nano, G; Nicolini, L; Russo, V; Topai, A; Zampella, G | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Björklund, E; Congiu, C; Fowler, CJ; Hempel, F; Onnis, V; Söderström, E | 1 |
| Deng, JY; Duan, XH; Jia, HM; Jin, B; Liu, BL; Yang, Y | 1 |
| Lund, C; Lynagh, T; Pless, SA; Romero-Rojo, JL | 1 |
1 review(s) available for ibuprofen, (r)-isomer and dexibuprofen
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
5 other study(ies) available for ibuprofen, (r)-isomer and dexibuprofen
| Article | Year |
|---|---|
2-Arylpropionic CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive CXCL8 inhibitors.
Topics: Animals; Binding Sites; Cell Line, Tumor; Cell Movement; Chemokines, CXC; Chemotaxis, Leukocyte; Female; Humans; Ketoprofen; Ligands; Lymphoma; Macrophages, Peritoneal; Mice; Models, Molecular; Mutagenesis, Site-Directed; Propionates; Receptors, Interleukin-8A; Recombinant Proteins; Structure-Activity Relationship | 2005 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors.
Topics: Amidohydrolases; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acids; Benzoates; Cell Line, Tumor; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Inhibitors; Inhibitory Concentration 50; Kinetics; Magnetic Resonance Spectroscopy; Polyunsaturated Alkamides; Pyridines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Spectrophotometry, Infrared; Structure-Activity Relationship | 2010 |
Novel imaging agents for β-amyloid plaque based on the N-benzoylindole core.
Topics: Amyloid beta-Peptides; Animals; Brain; Dose-Response Relationship, Drug; Indoles; Male; Mice; Mice, Inbred C57BL; Molecular Probes; Molecular Structure; Plaque, Amyloid; Stereoisomerism; Structure-Activity Relationship; Tissue Distribution | 2011 |
Molecular Basis for Allosteric Inhibition of Acid-Sensing Ion Channel 1a by Ibuprofen.
Topics: Acid Sensing Ion Channel Blockers; Acid Sensing Ion Channels; Allosteric Regulation; Animals; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Chick Embryo; Ibuprofen; Models, Molecular; Protein Conformation; Rats; Structure-Activity Relationship; Xenopus laevis | 2017 |